Shanghai, China — 26–29 August 2026 — Genèse Labs took part in IMCAS China 2026 in Shanghai, taking its first formal step into China’s aesthetic-medicine market and unveiling its new hydro-rejuvenation complex, Aqua Feel, for the first time. Over four days, the booth was thronged with local practitioners and distribution partners.

• First participation in the China edition of IMCAS, one of the world’s leading aesthetic congresses

• Debut of Aqua Feel — the booth’s biggest draw in a market that prizes dewy, glass-skin results

• In China, a leader in recombinant collagen, Proluma™ RH Collagen also drew strong interest

• Proluma™ PLA (PDLLA and PLLA) featured in the IMCAS product showcase

China is one of the fastest-growing aesthetic-medicine markets in the world, with very strong demand for non-surgical treatments and skin boosters. The China edition of Paris-born IMCAS is a leading scientific platform connecting local practitioners with global brands — the ideal first stage for Genèse Labs in China.

At the centre of the booth was Aqua Feel, unveiled here for the first time. Built on six key actives — including low- and high-molecular-weight hyaluronic acid, exosomes and sodium DNA — organised into three systems for deep hydration, regeneration and renewal, Aqua Feel was flooded with consultation requests from the first day and became the signature product of the show.

China is a market with a clear preference for deep hydration and radiance — so much so that “water-light” skin treatments have become mainstream. Aqua Feel’s popularity reflects exactly that. As a market with a highly developed recombinant collagen industry, China also prompted expert questions on Proluma™ RH Collagen, while the exosome-based Exoluma™ series enjoyed steady demand.

For four days the booth was constantly busy with practitioners and distributors eager to see the products first-hand, and the conversations begun here are now leading into partnership discussions in China. IMCAS China marks the opening of a new chapter in Genèse Labs’ Asian strategy.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, fillers, neuromodulators, and longevity and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, SofistiCa, AxeniQ™, NADX³, Aqua Feel, MESO PEPTA™, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.